​
​

Disc Medicine Stock (NASDAQ:IRON)

ForecastOwnershipFinancialsChart
Disc Medicine by TradingView

Previous Close

$48.27

52W Range

$25.60 - $77.60

50D Avg

$46.80

200D Avg

$49.52

Market Cap

$1.42B

Avg Vol (3M)

$299.86K

Beta

0.18

Div Yield

-

IRON Company Profile

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

78

IPO Date

Aug 12, 2020

Website

IRON Performance

IRON Financial Summary

Dec 23Dec 22Dec 21
Revenue---
Operating Income$-91.13M$-47.48M$-30.93M
Net Income$-76.43M$-46.09M$-41.01M
EBITDA$-91.13M$-47.48M$-25.85M
Basic EPS$-3.42$-8.87$-9.34
Diluted EPS$-3.42$-8.87$-9.34

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

TickerCompany
ANABAnaptysBio, Inc.
DICEDICE Therapeutics, Inc.
OLMAOlema Pharmaceuticals, Inc.
MORFMorphic Holding, Inc.
CNTACentessa Pharmaceuticals plc
LRMRLarimar Therapeutics, Inc.
MLYSMineralys Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
BMEABiomea Fusion, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
OBIOOrchestra BioMed Holdings, Inc.
FENCFennec Pharmaceuticals Inc.
TERNTerns Pharmaceuticals, Inc.
TRDAEntrada Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
MLTXMoonLake Immunotherapeutics
ABOSAcumen Pharmaceuticals, Inc.
GPCRStructure Therapeutics Inc.
ANEBAnebulo Pharmaceuticals, Inc.
ADAGAdagene Inc.
AMLXAmylyx Pharmaceuticals, Inc.